Diagnostics News and Research

RSS

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time.

17 May 2018

MIT researchers develop new versatile plug-and-play diagnostic devices

Researchers at MIT's Little Devices Lab have developed a set of modular blocks that can be put together in different ways to produce diagnostic devices.

17 May 2018

New insights regarding challenges in rare disease diagnosis, drug approval, and patient access

Value in Health, the official journal of ISPOR, announced today the publication of a series of articles offering important insight regarding the challenges in rare disease diagnosis, drug approval, and patient access.

17 May 2018

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

Record numbers of American veterans diagnosed with non-aggressive prostate cancer are heeding the advice of international medical experts and opting out of immediate surgery or radiation to treat their cancer.

16 May 2018

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit.

From Siemens Healthineers Point of Care Diagnostics 16 May 2018

First genomic survey of gonorrhea maps antibiotic resistance across Europe

The first European-wide genomic survey of gonorrhea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent.

16 May 2018

Drug-resistant staph infections found to be deadly, but less costly

Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.

15 May 2018

UTA bioengineering professor successfully patents new cancer trap

The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.

14 May 2018

New combined risk score shows improved effectiveness in predicting stroke risk of Afib patients

Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.

11 May 2018

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

From HORIBA Medical 11 May 2018

Biosense Webster enrolls and treats first patient in QDOT AF study

Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its QDOT AF Study.

From Johnson & Johnson 11 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a simple blood test.

10 May 2018

New lab-on-a-chip device shows promise in treating retinal diseases

Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.

10 May 2018

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Today physicians are still severely hampered by the lack of precision of the needle tip location during a biopsy. Looking at lung cancers, 25% of the diagnoses suffer a false negative outcome through traditional biopsy methods. In the future, this can be avoided: for the first time, the European project InSPECT developed miniature spectrometers with integrated light sources enabling guided sensing.

8 May 2018

Study identifies new biomarker for early lung cancer diagnosis

High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.

8 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Diagnostics News and Research

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

MIT researchers develop new versatile plug-and-play diagnostic devices

New insights regarding challenges in rare disease diagnosis, drug approval, and patient access

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

First genomic survey of gonorrhea maps antibiotic resistance across Europe

Drug-resistant staph infections found to be deadly, but less costly

UTA bioengineering professor successfully patents new cancer trap

New combined risk score shows improved effectiveness in predicting stroke risk of Afib patients

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

Biosense Webster enrolls and treats first patient in QDOT AF study

Addressing Antimicrobial Resistance Through Industry

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

New lab-on-a-chip device shows promise in treating retinal diseases

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Study identifies new biomarker for early lung cancer diagnosis

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Tradeshow Talks with Molbio Diagnostics Ltd

NucleoBio's new test kit could accurately reveal results of prostate cancer screening

New technique developed to improve diagnosis of vision disorders

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News